Poland· PL-100402362
Xaleba
A etoricoxib product containing etoricoxibum, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Etoricoxib is registered in 15 of 19 countries.
Countries holding a registration under ATC M01AH05 (etoricoxib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Etoricoxib · ATC M01AH05
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of etoricoxib costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.36 in France to $2.64 in Switzerland — a ×7.3 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Etoricoxib · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.64
- ES Spain$0.44
- IT Italy$0.36
- FR France$0.36
The record
At a glance
URPL (Poland)- Active substance
- Etoricoxibum
- Manufacturer
- Accord Healthcare Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- M01AH05
- ATC class
- Etoricoxib
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 17
- gtin05909991399962
- gtin05909991399979
- gtin05909991399986
- gtin05909991399993
- gtin05909991400002
- gtin05909991400019
- gtin05909991400026
- gtin05909991400033
- gtin05909991400040
- gtin05909991400057
- gtin05909991400064
- gtin05909991400071
- gtin05909991400088
- gtin05909991400095
- gtin05909991400101
- gtin05909991400118
- gtin05909991400125
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
29 interactions on record for etoricoxib.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Etoricoxib · interactions on record
29 records
29 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Etoricoxib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainACOXXEL 120 mg COMPRIMIDOS RECUBIERTOS CON PELICULAOrganon Salud S.L.
- NetherlandsArcoxia 120 mg filmomhulde tablettenN.V. Organon
- CzechiaROTICOXKrka, d.d., Novo mesto, Novo mesto
- FinlandArcoxiaN.V. Organon
- ItalyALGIXNEOPHARMED GENTILI S.P.A.
- SwedenArcoxia 120 mg Filmdragerad tablettOrganon N.V
- BelgiumArcoxia 120 mgPI Pharma
- IrelandArcoxia 120 mg film-coated tabletsNV Organon
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Arcoxia, Etoricoxib Sandoz
- Belgium · Arcoxia, Etoricoxib Ab
- Bulgaria · Аркоксия, Долоксиб
- Cyprus · Arcoxia, Eritox
- Czechia · Arcoxia, Roticox
- Germany · Acoxxel, Arcoxia
- Denmark · Arcoxia, Etoricoxib Krka
- Estonia · Arcoxia, Bicoret
- Spain · Acoxxel, Arcoxia
- Finland · Arcoxia, Etoricoxib Krka
- France · Arcoxia, Etoricoxib Arrow
- United Kingdom (Northern Ireland) · Arcoxia, Etoricoxib
- Greece · Arcoxia, Erciba
- Croatia · Arcoxia, Etorikoksib Jgl 60 Mg Tablete
- Hungary · Arcoxia, Etoriax
- Ireland · Arcoxia, Etoricoxib Accord Healthcare
- Iceland · Arcoxia, Coxerit
- Italy · Algix, Arcoxia
- Lithuania · Arcoxia, Bericox
- Luxembourg · Arcoxia, Etoricoxib Eg
- Latvia · Arcoxia, Bericox
- Malta · Arcoxia, Etoriax
- Netherlands · Arcoxia, Ecoxyton
- Norway · Arcoxia, Etoricoxib Krka
- Portugal · Acoxxel, Arcoxia
- Romania · Arcoxia, Doloxib
- Sweden · Arcoxia, Etoricoxib Brown
- Slovenia · Arcoxia, Coxeta
- Slovakia · Roticox
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bbdb3bae-e7c0-4645-ba17-0a84268a7b43 GET /v1/drugs/bbdb3bae-e7c0-4645-ba17-0a84268a7b43?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "120 mg",
"packaging": "05909991399962 ¦ Rp ¦ 132218\n2 tabl.\n05909991399979 ¦ Rp ¦ 132219\n5 tabl. w blistrze perforowanym\n05909991399986 ¦ Rp ¦ 132220\n5 tabl. w blistrze\n05909991399993 ¦ Rp ¦ 132221\n7 tabl.\n05909991400002 ¦ Rp ¦ 132222\n10 tabl.\n05909991400019 ¦ Rp ¦ 132223\n14 tabl.\n05909991400026 ¦ Rp ¦ 132224\n20 tabl.\n05909991400033 ¦ Rp ¦ 132225\n28 tabl.\n05909991400040 ¦ Rp ¦ 132226\n30 tabl.\n05909991400057 ¦ Rp ¦ 132227\n49 tabl.\n05909991400064 ¦ Rp ¦ 132228\n50 tabl. w blistrze perforowanym\n05909991400071 ¦ Rp ¦ 132229\n84 tabl.\n05909991400088 ¦ Rp ¦ 132230\n98 tabl.\n05909991400095 ¦ Rp ¦ 132231\n98 tabl. (2 x 49)\n05909991400101 ¦ Rp ¦ 132232\n100 tabl. w blistrze\n05909991400118 ¦ Rp ¦ 132233\n100 tabl. w blistrze perforowanym\n05909991400125 ¦ Rp ¦ 132234\n50 tabl. w blistrze",
"substance": "Etoricoxibum 120 mg",
"common_name": "Etoricoxibum",
"pl_product_id": "100402362",
"pozwolenie_nr": "25274",
"auth_procedure": "MRP",
"authorisation_validity": "2025-07-14"
}See everything about etoricoxib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.